Docetaxel, Carboplatin, and Bevacizumab in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer That Can Be Removed By Surgery

Clinical trial NCT00293332 · TERMINATED

Trial details

NCT number

NCT00293332

Sponsor

University of California, San Francisco

Status

TERMINATED

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2005-12-01

Primary completion

2007-03-01

Enrollment

1

View on ClinicalTrials.gov